Reviva Pharmaceuticals Stock Forecast - Naive Prediction

RVPH Stock  USD 0.37  0.02  5.71%   
The Naive Prediction forecasted value of Reviva Pharmaceuticals Holdings on the next trading day is expected to be 0.41 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.26. Reviva Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Reviva Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 9th of January 2026, the RSI of Reviva Pharmaceuticals' share price is approaching 42 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Reviva Pharmaceuticals, making its price go up or down.

Momentum 42

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Reviva Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Reviva Pharmaceuticals Holdings, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Reviva Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(0.10)
EPS Estimate Current Year
(0.33)
EPS Estimate Next Year
(0.27)
Wall Street Target Price
4.8125
EPS Estimate Current Quarter
(0.1)
Using Reviva Pharmaceuticals hype-based prediction, you can estimate the value of Reviva Pharmaceuticals Holdings from the perspective of Reviva Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Reviva Pharmaceuticals using Reviva Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Reviva using crowd psychology based on the activity and movement of Reviva Pharmaceuticals' stock price.

Reviva Pharmaceuticals Short Interest

A significant increase or decrease in Reviva Pharmaceuticals' short interest from the previous month could be a good indicator of investor sentiment towards Reviva. Short interest can provide insight into the potential direction of Reviva Pharmaceuticals stock and how bullish or bearish investors feel about the market overall.
200 Day MA
0.5939
Short Percent
0.2329
Short Ratio
5.84
Shares Short Prior Month
23.2 M
50 Day MA
0.5226

Reviva Pharmaceuticals Hype to Price Pattern

Investor biases related to Reviva Pharmaceuticals' public news can be used to forecast risks associated with an investment in Reviva. The trend in average sentiment can be used to explain how an investor holding Reviva can time the market purely based on public headlines and social activities around Reviva Pharmaceuticals Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Reviva Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Reviva Pharmaceuticals.

Reviva Pharmaceuticals Implied Volatility

    
  1.07  
Reviva Pharmaceuticals' implied volatility exposes the market's sentiment of Reviva Pharmaceuticals Holdings stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Reviva Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Reviva Pharmaceuticals stock will not fluctuate a lot when Reviva Pharmaceuticals' options are near their expiration.
The Naive Prediction forecasted value of Reviva Pharmaceuticals Holdings on the next trading day is expected to be 0.41 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.26.

Reviva Pharmaceuticals after-hype prediction price

    
  USD 0.37  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Reviva Pharmaceuticals to cross-verify your projections.
The current Payables Turnover is estimated to decrease to 0.58. The Reviva Pharmaceuticals' current Common Stock Shares Outstanding is estimated to increase to about 40 M, while Net Loss is forecasted to increase to (20.8 M).

Open Interest Against 2026-04-17 Reviva Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Reviva Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Reviva Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Reviva Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Reviva Pharmaceuticals' open interest, investors have to compare it to Reviva Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Reviva Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Reviva. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Reviva Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Reviva price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Reviva using various technical indicators. When you analyze Reviva charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Reviva Pharmaceuticals Cash Forecast

Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the Reviva Pharmaceuticals' financial statements, enabling forecasts of their impact on future stock prices.
 
Cash  
First Reported
2019-09-30
Previous Quarter
10.4 M
Current Value
13.2 M
Quarterly Volatility
10.6 M
 
Covid
A naive forecasting model for Reviva Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Reviva Pharmaceuticals Holdings value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Reviva Pharmaceuticals Naive Prediction Price Forecast For the 10th of January

Given 90 days horizon, the Naive Prediction forecasted value of Reviva Pharmaceuticals Holdings on the next trading day is expected to be 0.41 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 3.26.
Please note that although there have been many attempts to predict Reviva Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Reviva Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Reviva Pharmaceuticals Stock Forecast Pattern

Backtest Reviva PharmaceuticalsReviva Pharmaceuticals Price PredictionBuy or Sell Advice 

Reviva Pharmaceuticals Forecasted Value

In the context of forecasting Reviva Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Reviva Pharmaceuticals' downside and upside margins for the forecasting period are 0 and 10.34, respectively. We have considered Reviva Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.37
0.41
Expected Value
10.34
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Reviva Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Reviva Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria112.6312
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0534
MAPEMean absolute percentage error0.111
SAESum of the absolute errors3.2555
This model is not at all useful as a medium-long range forecasting tool of Reviva Pharmaceuticals Holdings. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Reviva Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Reviva Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Reviva Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.020.3710.22
Details
Intrinsic
Valuation
LowRealHigh
0.020.3710.22
Details
6 Analysts
Consensus
LowTargetHigh
4.384.815.34
Details

Other Forecasting Options for Reviva Pharmaceuticals

For every potential investor in Reviva, whether a beginner or expert, Reviva Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Reviva Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Reviva. Basic forecasting techniques help filter out the noise by identifying Reviva Pharmaceuticals' price trends.

Reviva Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reviva Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reviva Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reviva Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Reviva Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Reviva Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Reviva Pharmaceuticals' current price.

Reviva Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Reviva Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reviva Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reviva Pharmaceuticals stock market strength indicators, traders can identify Reviva Pharmaceuticals Holdings entry and exit signals to maximize returns.

Reviva Pharmaceuticals Risk Indicators

The analysis of Reviva Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Reviva Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting reviva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Reviva Pharmaceuticals to cross-verify your projections.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.44)
Return On Assets
(1.30)
Return On Equity
(9.16)
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.